Pfizer Inc.

NYSE:PFE   1:52:40 PM EDT
39.58
+0.16 (+0.39%)
Products

U.S. FDA Approves Prevnar 20™, Pfizer'S Pneumococcal 20-Valent Conjugate Vaccine For Adults Ages 18 Years Or Older

Published: 06/08/2021 23:24 GMT
Pfizer Inc. (PFE) - U.S. FDA Approves Prevnar 20™, Pfizer’s Pneumococcal 20-valent Conjugate Vaccine for Adults Ages 18 Years Or Older.
Pfizer - Following FDA Approval Cdc's Committee on Immunization Practices Expected to Meet in October.
Pfizer-advisory Committee on Immunization Practices to Discuss,update Recommendations on Safe, Appropriate Use of Pneumococcal Vaccines in Adults.
Pfizer - FDA's Decision is Based on Evidence From Pfizer's Clinical Program in Adults, Including Phase 1 and 2 Trials, and Three Phase 3 Trials.